Today: 8 November 2025
Subscribe
Browse Category

Investing News 22 October 2025 - 23 October 2025

Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon’s Wild Ride: From Plunge to 420% Pop Abroad Axon’s stock has been on a rollercoaster in late October. Last week, shares suddenly plunged ~8.5% in one day, falling from the $700s to about $645 ts2.tech. Notably, this dive occurred despite no major negative news from the company – a stark contrast to the modest uptick in the broader market that day ts2.tech. Market watchers suggest the drop was triggered by technical trading: the sell-off pushed AXON below a key support (its 200-day average), likely triggering stop-loss orders and momentum selling ts2.tech. Indeed, analysts at TheStreet “do not see any
23 October 2025
 ·  ·  ·  ·  · 
Netflix Crashes 10%, Tesla’s Big Miss Rattles Markets – Is the Rally Hitting a Wall?

Netflix Crashes 10%, Tesla’s Big Miss Rattles Markets – Is the Rally Hitting a Wall?

Stocks Hit a Speed Bump Amid Tech Earnings Jitters After a powerful run fueled by tech euphoria this year, global equities abruptly lost altitude this week. On October 22, the Dow sank 334 points (0.7%) to ~46,590, the S&P 500 shed 0.5%, and the Nasdaq Composite nearly 0.9% reuters.com. Investors faced a flurry of bad news: a shocking plunge in Netflix shares, underwhelming results from Tesla, and new trade and regulatory clouds hanging over the tech sector. “U.S. stocks fell on Wednesday, as [a report of potential U.S. export curbs to China] ratcheted up trade war fears and added to
23 October 2025
 ·  ·  ·  ·  ·  · 
AI Frenzy Fuels Record Wall St Rally as Shutdown Drags On – Key Market News (Oct 6-7, 2025)

Stock Market Today 23.10.2025

ENDEDLive coverage has endedEnded: October 25, 2025, 6:00 AM EDT West Pharmaceutical Services Q3 Profit Beats Estimates, Raises FY25 Guidance (WST) October 23, 2025, 7:22 AM EDT. West Pharmaceutical Services (WST) reported a Q3 profit of $140.0 million, or $1.92 per share (GAAP), up from $136.0 million, $1.85 a year earlier. Excluding items, adjusted earnings rose to $142.4 million, or $1.96 per share, versus consensus of about $1.69. Revenue climbed 7.7% to $804.6 million from $746.9 million. Looking ahead, the company issued next-quarter guidance of $1.81-$1.86 for EPS and $790-$800 million for revenue. For FY25, West raised its adjusted-diluted EPS
23 October 2025
 ·  ·  ·  · 
Erie Indemnity Stock Tanks 40% – Is This Insurance Play Now a Bargain?

Erie Indemnity Stock Tanks 40% – Is This Insurance Play Now a Bargain?

Solid Fundamentals, Sluggish Stock Erie Indemnity, founded in 1925 and based in Pennsylvania, acts as the management company for Erie Insurance (a mutual P&C insurer) marketbeat.com barchart.com. Its revenue comes largely from management fees tied to premium growth. In Q2 2025, ERIE saw net income rise to $174.7M ($3.34 per diluted share), up from $163.9M ($3.13) a year earlier stocktitan.net finimize.com. Growth was driven by a premium-fueled 8.3% jump in management fees (to $823.9M) and a doubling of investment income to $19.6M stocktitan.net finimize.com. Despite the gains, expenses grew – commissions and IT costs rose to support higher sales –
23 October 2025
 ·  ·  ·  · 
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds Shares Hit Decade-High Despite £2 Billion Scandal – What’s Next for LLOY Stock?

Lloyds Share Price Rally Nears 10-Year High Lloyds Banking Group (LSE: LLOY) stock has been on a tear in 2025, flirting with decade highs. Shares currently trade around 84–85 pence, just shy of their highest level since 2015 ts2.tech. In mid-October, Lloyds hit ~86.6p, a level not seen since before the Brexit referendum, underscoring the bank’s remarkable recovery. The stock has climbed roughly 50% year-on-year, vastly outperforming the broader FTSE 100 index ts2.tech. Elevated interest rates have turbocharged bank earnings, and Lloyds – as the UK’s largest retail lender – has been a prime beneficiary of fatter loan margins. Investors
23 October 2025
 ·  ·  ·  · 
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets 3,000% — Is the Rally Sustainable?

Latest Stock Price and Performance D-Wave’s stock has been on a wild ride. After spending most of 2024 under $5, QBTS erupted in 2025. It surged into the mid-$40s in mid-October, hitting $46.75 on Oct. 15 ts2.tech. That came after several back-to-back gains – for instance, a 23% jump on Oct. 13 alone ts2.tech. By Oct. 22, the stock had retreated; it closed around $27.29 on Oct. 22 stockanalysis.com and traded near $26.78 in after-hours that evening stockanalysis.com. Reuters reports QBTS “trading lower” at $27.29 as of Oct. 23 reuters.com. In total, QBTS is up roughly 300% so far in
23 October 2025
 ·  ·  ·  ·  · 
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Quantum Gold or Bubble? Rigetti (RGTI) Stock Skyrockets 5,000% Then Crashes to $36

Stock Performance & Recent Trading Rigetti’s stock has been on a rollercoaster. After languishing under $1 early in 2025, RGTI soared to $56.34 on Oct. 15 (a nearly 50× Y/Y gain) ts2.tech. But the rally ran into profit-taking and market jitters. On Oct. 16, RGTI plunged ~15% intraday, slipping from the $50s into the high-$40s ts2.tech. This slide extended over the week: by Oct. 20 it was in the mid-$40s ts2.tech, by Oct. 21 it closed around $40.00 ts2.tech, and on Oct. 22 it closed $36.06 investing.com (down 9.85% that day). All told, the stock gave back about 25% of
23 October 2025
 ·  ·  ·  ·  · 
Lam Research Stock Rockets on AI Chip Demand – Can LRCX Keep Climbing?

Lam Research Stock Rockets on AI Chip Demand – Can LRCX Keep Climbing?

Earnings Beat on Surging Demand Lam Research (NASDAQ:LRCX) handily beat forecasts for its fiscal Q1, as demand for cutting-edge chipmaking gear remains hot. The Fremont, CA company reported $5.32 billion in revenue and $1.26 EPS (non-GAAP) for Q1, versus analyst estimates of $5.22 B and $1.21 timesunion.com investing.com. On a GAAP basis Lam earned $1.57 B ($1.24 per share) timesunion.com. These results, aided by strong year-on-year growth in both logic and memory equipment, “significantly surpassed analyst expectations” and underscore Lam’s role as a bellwether of chipmakers’ AI-driven spending markets.financialcontent.com investing.com. Management’s guidance was equally positive. Lam forecast Q2 revenue of ~$5.20 B (±$0.3B) and
22 October 2025
 ·  ·  ·  ·  · 
Centrus Energy’s Multi-Billion Nuclear Bet Pays Off – LEU Stock Skyrockets on Uranium Boom

Centrus Energy’s Nuclear High Fades: LEU Stock Plummets 20% After 400% Rally – What’s Going On?

LEU Stock’s Wild Ride – From Nuclear Euphoria to 20% Plunge Centrus Energy’s stock has been on a rollercoaster in 2025, exhilarating investors with a massive rally before suffering a brutal pullback. The company’s share price skyrocketed over 400% this year amid surging nuclear enthusiasm ts2.tech. By mid-October, LEU had spiked to an intraday high of about $464 – an astounding 9× jump from roughly $50 one year ago investing.com ts2.tech. This breathtaking rally made Centrus one of the top-performing energy stocks of 2025 ts2.tech. However, that euphoria abruptly reversed this past week. After peaking on Oct. 16, Centrus shares
22 October 2025
 ·  ·  ·  ·  · 
Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results

Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results

Armata’s stock performance this week has been nothing short of dramatic. Prior to Oct. 22, ARMP had been trading in the low-$3 range (for example, it closed around $3.41 on Oct. 16 marketbeat.com). Once the late-breaking IDWeek data was announced, the shares rocketed – briefly hitting an intraday high near $16 (per some quotes) before settling at about $8.87 finviz.com investing.com. For context, that $8.87 close is the stock’s highest level in years (FinViz shows a 52-week high of only $3.50 prior to today). By midday on Oct. 22, Investing.com already noted the stock was up ~95% on the day
22 October 2025
 ·  ·  ·  · 
Hut 8 Stock Skyrockets on Bitcoin Boom, Trump-Backed Spinoff Debut, and Bold Energy Pivot

Hut 8 Stock on Wild Ride as Bitcoin Boom, Trump Spinoff Fuel Soaring Rally – What’s Next for HUT?

Bitcoin Boom Propels Hut 8 to Record Highs (Then a Pullback) Hut 8 stock has been on a roller coaster in October 2025, mirroring the volatility of the crypto market. In the first half of the month, HUT rode a wave of euphoria as Bitcoin’s price rocketed to levels not seen in years. Bitcoin briefly topped $115,000–$120,000 in early October ts2.tech ts2.tech, driven by optimism around a possible U.S. Bitcoin ETF approval and a crypto-friendly regulatory climate. This Bitcoin boom translated into amplified gains for mining stocks – high-beta plays that tend to outperform the underlying asset’s moves. Hut 8’s shares
22 October 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% on Crypto Boom, S&P 500 Debut – What’s Next?

HOOD Stock’s 2025 Surge and Recent Pullback Robinhood’s stock has been on a tear in 2025, vastly outperforming the broader market ts2.tech. After starting the year in the low $30s, HOOD rocketed past $100 over the summer and kept climbing. The rally hit a peak in early October when shares reached about $153, marking a record high for the company ts2.tech. This climb coincided with a major milestone: Robinhood’s inclusion in the S&P 500 index at the end of September, which was hailed as a “watershed moment” for fintech’s legitimacy ts2.tech. Joining the benchmark index not only validated Robinhood as
22 October 2025
 ·  ·  ·  ·  · 
1 … 27 28 29 30 31 … 67
Go toTop